Literature DB >> 3260018

[3H]inositol 1,4,5-triphosphate binding in human cerebral cortex.

L T Young1, P P Li, S J Kish, A S Chiu, J J Warsh.   

Abstract

Specific, saturable and reversible binding of [3H]inositol 1,4,5-triphosphate (IP3) was demonstrated to membranes prepared from autopsied cerebral cortices from 6 subjects who were free from psychiatric or neurological disease. The binding has an affinity of 27 +/- 8 nM (mean +/- S.E.M.); capacity (Bmax) of 1.09 +/- 0.18 pmol/mg protein and is reversible in the presence of an excess of unlabelled IP3. These [3H]IP3 binding sites are likely to be physiologically significant receptors which merit further characterization in the normal and diseased human brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260018     DOI: 10.1016/0304-3940(88)90462-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Autoradiographic characterization of [3H]inositol (1,4,5) trisphosphate and [3H]inositol (1,3,4,5) tetrakisphosphate binding sites in human brain.

Authors:  T Kurumatani; R F Cowburn; N Bogdanovic; B Winblad; J Fastbom
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Characteristics of [3H]inositol(1,3,4,5)tetrakisphosphate recognition sites in human cerebellar membranes.

Authors:  A Garlind; R F Cowburn; C J Fowler
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Solubilization and separation of inositol 1,3,4,5-tetrakisphosphate- and inositol 1,4,5-trisphosphate-binding proteins and metabolizing enzymes in rat brain.

Authors:  A B Theibert; S Supattapone; C D Ferris; S K Danoff; R K Evans; S H Snyder
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

4.  Inositol 1,4,5-trisphosphate binding sites in the brain: regional distribution, characterization, and alterations in brains of patients with Parkinson's disease.

Authors:  N Kitamura; T Hashimoto; N Nishino; C Tanaka
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.